Opus Genetics, Inc. Common Stock (NASDAQ: IRD) last traded at $4.65, up 4.26% on the session. The quote above updates while this page is open; the figures below are drawn from Opus Genetics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Opus Genetics, Inc. Common Stock trades on NASDAQ under the ticker IRD. Its market capitalisation is $386.86 million.
Valuation measures for Opus Genetics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $386.86M |
|---|---|
| Enterprise value | $404.00M |
| Price / sales | 39.25 |
| Beta | 1.03 |
Trailing-twelve-month figures tagged in Opus Genetics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $9.86M |
| Net income (TTM) | -$107.61M |
|---|
| EPS (TTM) | -$1.33 |
|---|
| Operating margin | -513.47% |
|---|
| Cash | $88.81M |
|---|
Range and volume for IRD over the past 52 weeks.
| 52-week high | $7.07 |
|---|---|
| 52-week low | $1.70 |
| Volume | 1.26M |
| Average volume | 2.36M |
| Previous close | $4.46 |
Invest a chosen dollar amount in Opus Genetics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IRD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.